×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CVKD – cadrenal therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CVKD
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/7
01:45 pm
cvkd
Cadrenal Therapeutics (CVKD) had its price target lowered by HC Wainwright from $32.00 to $13.00. They now have a "buy" rating on the stock.
Low
Report
Cadrenal Therapeutics (CVKD) had its price target lowered by HC Wainwright from $32.00 to $13.00. They now have a "buy" rating on the stock.
3/31
08:45 am
cvkd
Cadrenal Therapeutics Reports Fourth Quarter 2025 Financial Results; Provides Corporate Update on CAD-1005 Program for HIT Following End-of-Phase 2 FDA Meeting
High
Report
Cadrenal Therapeutics Reports Fourth Quarter 2025 Financial Results; Provides Corporate Update on CAD-1005 Program for HIT Following End-of-Phase 2 FDA Meeting
3/12
08:00 am
cvkd
Cadrenal Therapeutics Highlights Research Supporting 12-LOX Inhibition in Reducing Inflammation in Obesity and Type 2 Diabetes
Medium
Report
Cadrenal Therapeutics Highlights Research Supporting 12-LOX Inhibition in Reducing Inflammation in Obesity and Type 2 Diabetes
3/2
08:28 am
cvkd
Cadrenal Therapeutics Highlights Recent 12-LOX Inhibitor Platform Expansion [Yahoo! Finance]
Low
Report
Cadrenal Therapeutics Highlights Recent 12-LOX Inhibitor Platform Expansion [Yahoo! Finance]
3/2
08:00 am
cvkd
Cadrenal Therapeutics Highlights Recent 12-LOX Inhibitor Platform Expansion
Low
Report
Cadrenal Therapeutics Highlights Recent 12-LOX Inhibitor Platform Expansion
2/25
04:42 pm
cvkd
CVKD: Phase 2 HIT Results Show Encouraging Reduction in Thrombotic Events [Yahoo! Finance]
Medium
Report
CVKD: Phase 2 HIT Results Show Encouraging Reduction in Thrombotic Events [Yahoo! Finance]
2/24
08:30 am
cvkd
Cadrenal Therapeutics Announces Phase 2 Results with Encouraging Reductions in Thrombotic Events for CAD-1005 in HIT, Supporting Clinical Advancement
High
Report
Cadrenal Therapeutics Announces Phase 2 Results with Encouraging Reductions in Thrombotic Events for CAD-1005 in HIT, Supporting Clinical Advancement
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/1
07:40 am
cvkd
Form 8-K Cadrenal Therapeutics, For: Mar 31
Medium
Report
Form 8-K Cadrenal Therapeutics, For: Mar 31
4/1
07:30 am
cvkd
Form 424B5 Cadrenal Therapeutics,
Medium
Report
Form 424B5 Cadrenal Therapeutics,
3/31
09:02 am
cvkd
Form 10-K Cadrenal Therapeutics, For: Dec 31
High
Report
Form 10-K Cadrenal Therapeutics, For: Dec 31
3/31
08:55 am
cvkd
Form 8-K Cadrenal Therapeutics, For: Mar 31
High
Report
Form 8-K Cadrenal Therapeutics, For: Mar 31
3/12
08:06 am
cvkd
Form 8-K Cadrenal Therapeutics, For: Mar 12
Medium
Report
Form 8-K Cadrenal Therapeutics, For: Mar 12
2/24
08:36 am
cvkd
Form 8-K Cadrenal Therapeutics, For: Feb 24
High
Report
Form 8-K Cadrenal Therapeutics, For: Feb 24
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: